Corrigendum: Cetuximab rechallenge in metastatic colorectal cancer patients: How to come away from acquired resistance?: [Ann Oncol, 23, 9, (2012) (2313-2318)] doi: 10.1093/annonc/mdr623

Additional Metadata
Persistent URL	doi.org/10.1093/annonc/mdw551, hdl.handle.net/1765/103041
Journal	Annals of Oncology
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Santini, D., Vincenzi, B., Addeo, R., Garufi, C., Masi, G., Scartozzi, M., Mancuso, A. (A.), Frezza, A. M., Venditti, O., Imperatori, M., Schiavon, G., Bronte, G., Cicero, G. (G.), Recine, F., Maiello, E. (E.), Cascinu, S., Russo, A. (A.), Falcone, A.& Tonini, G. (2017). Corrigendum: Cetuximab rechallenge in metastatic colorectal cancer patients: How to come away from acquired resistance?: [Ann Oncol, 23, 9, (2012) (2313-2318)] doi: 10.1093/annonc/mdr623. Annals of Oncology, 28(11).https://doi.org/10.1093/annonc/mdw551

Corrigendum: Cetuximab rechallenge in metastatic colorectal cancer patients: How to come away from acquired resistance?